• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A physiological model for the distribution of injected agents, with special reference to pethidine.

作者信息

Davis N R, Mapleson W W

机构信息

Department of Anaesthetics, University of Wales College of Medicine, Heath Park, Cardiff.

出版信息

Br J Anaesth. 1993 Mar;70(3):248-58. doi: 10.1093/bja/70.3.248.

DOI:10.1093/bja/70.3.248
PMID:8471365
Abstract

The model is based on Mapleson's Model P for inhaled anaesthetics, but has compartments for lungs, peripheral shunt, kidneys, portal bed, liver, other viscera, muscle, other lean, fat, brain, i.m. injection site and for various blood "pools". Intracellular and extracellular fluids are represented separately in each compartment and in blood. In each fluid, four forms of the agent are distinguished: unionized dissolved in water ("standard" form), ionized dissolved in water, unionized dissolved in lipid, and bound to protein. Equations define the equilibrium between these four forms in any one fluid and between blood and tissue. After changing two of the more uncertain numbers in the quantification for pethidine, good agreement was obtained between computed and published venous concentrations after single i.v. and i.m. injections, continuous i.v. infusions and repeated i.m. injections. The model can be used to make a wide variety of "what if" predictions.

摘要

相似文献

1
A physiological model for the distribution of injected agents, with special reference to pethidine.
Br J Anaesth. 1993 Mar;70(3):248-58. doi: 10.1093/bja/70.3.248.
2
Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics.注射剂与吸入麻醉剂分布的生理模型的结构与量化
Br J Anaesth. 1981 Apr;53(4):399-405. doi: 10.1093/bja/53.4.399.
3
Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model.利用生理血流模型分析孕鼠体内哌替啶的处置情况。
J Pharmacokinet Biopharm. 1986 Aug;14(4):381-95. doi: 10.1007/BF01059198.
4
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.基于生理的药代动力学模型的简化与归并:通过逐步简化模型预测芬太尼和哌替啶在人体内的处置情况
J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):285-307. doi: 10.1023/a:1026194618660.
5
Pulmonary disposition of pethidine in postoperative patients.哌替啶在术后患者中的肺部处置情况。
Br J Clin Pharmacol. 1988 Feb;25(2):235-41. doi: 10.1111/j.1365-2125.1988.tb03296.x.
6
Pharmacokinetics of i.v. and rectal pethidine in children undergoing ophthalmic surgery.眼科手术患儿静脉注射及直肠给药哌替啶的药代动力学
Br J Anaesth. 1993 Dec;71(6):823-6. doi: 10.1093/bja/71.6.823.
7
The in vitro uptake and metabolism of lignocaine, procainamide and pethidine by tissues of the hindquarters of sheep.利多卡因、普鲁卡因胺和哌替啶在绵羊后肢组织中的体外摄取与代谢
Xenobiotica. 1991 Jan;21(1):1-12. doi: 10.3109/00498259109039445.
8
Rate of formation of norpethidine from pethidine.哌替啶去甲哌替啶的生成速率。
Br J Anaesth. 1981 Mar;53(3):255-8. doi: 10.1093/bja/53.3.255.
9
Pethidine revisited: plasma concentrations and effects after intramuscular injection.哌替啶再探讨:肌内注射后的血药浓度及效应
Br J Anaesth. 1975 Dec;47(12):1269-75. doi: 10.1093/bja/47.12.1269.
10
[Distribution of 14C-pethidine in the blood of certain species].[14C-哌替啶在某些物种血液中的分布]
Cesk Farm. 1989 Oct;38(8):348-50.

引用本文的文献

1
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK Modeling.使用生理药代动力学(PBPK)模型分析产前宫内暴露于接受肌肉注射剂量的母亲的新生儿唾液、血浆和脑细胞外液中的哌替啶药代动力学。
Eur J Drug Metab Pharmacokinet. 2023 May;48(3):281-300. doi: 10.1007/s13318-023-00823-x. Epub 2023 Apr 5.
2
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.理解药代动力学/药效动力学关系中的滞后环难题。
J Pharm Pharm Sci. 2014;17(1):34-91.
3
Mechanistic approaches to volume of distribution predictions: understanding the processes.
分布容积预测的机制方法:理解相关过程
Pharm Res. 2007 May;24(5):918-33. doi: 10.1007/s11095-006-9210-3. Epub 2007 Mar 20.
4
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.基于生理学的药代动力学建模:需要坚实的机制基础。
Br J Clin Pharmacol. 2005 Dec;60(6):581-3. doi: 10.1111/j.1365-2125.2005.02560.x.
5
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.基于生理的药代动力学模型的简化与归并:通过逐步简化模型预测芬太尼和哌替啶在人体内的处置情况
J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):285-307. doi: 10.1023/a:1026194618660.
6
PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.PKQuest:挥发性溶质——在安氟醚、氧化亚氮、氟烷、甲氧氟烷和甲苯药代动力学中的应用
BMC Anesthesiol. 2002 Aug 15;2(1):5. doi: 10.1186/1471-2253-2-5.
7
Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.基于参数化单组织模型的大鼠和人类中芬太尼与阿芬太尼的比较生理药代动力学
J Pharmacokinet Biopharm. 1994 Oct;22(5):381-410. doi: 10.1007/BF02353862.